Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Cadila forms JV with Novavax to develop vaccines in India

Executive Summary

Indian pharma company Cadila Pharmaceuticals and Novavax (vaccines for infectious diseases) have formed CPL Biologicals Ltd., a joint venture to develop and market Novavax's seasonal influenza virus-like-particle-based (VLP) vaccine drug candidate and Cadila's cancer vaccines, adjuvants, biogeneric products, and diagnostics in India.

Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
    • Specialty Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Liposomes
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity
    • Joint Venture
    • R&D and Marketing (Licensing)

Related Companies